mRNA and DNA-Based Vaccines in Genitourinary Cancers: A New Frontier in Personalized Immunotherapy

Genitourinary (GU) cancers, including prostate, bladder, and renal cancers, represent a significant burden on global health. Conventional treatments, while effective in certain contexts, face limitations due to tumor heterogeneity, therapeutic resistance, and relapse. Recent advances in cancer immun...

Descripción completa

Detalles Bibliográficos

Autores principales:	Jasmine Vohra, Gabriela Rodrigues Barbosa, Leonardo O. Reis
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2025-08-01
Colección:	Vaccines
Materias:	mRNA vaccines DNA vaccines genitourinary cancer prostate cancer bladder cancer renal cell carcinoma
Acceso en línea:	https://www.mdpi.com/2076-393X/13/9/899
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!